Showing posts with label cells. Show all posts
Showing posts with label cells. Show all posts

Thursday, September 19, 2013

0 Dendritic Cells: Cellular Mediators for Immunological Tolerance

Clinical and Developmental Immunology Volume 2013 (2013), Article ID 972865, 8 pages http://dx.doi.org/10.1155/2013/972865

Review Article

Dendritic Cells: Cellular Mediators for Immunological Tolerance



1Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp University Hospital (UZA), Wilrijkstraat 10, 2650 Edegem, Belgium
2Department of Hepatobiliary, Transplantation, and Endocrine Surgery, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp University Hospital (UZA), Wilrijkstraat 10, 2650 Edegem, Belgium
3Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital (UZA), Wilrijkstraat 10, 2650 Edegem, Belgium

Received 1 February 2013; Accepted 7 April 2013

Academic Editor: Mohamad Mohty


Copyright © 2013 Chun Yuen J. Chung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.



Abstract


In general, immunological tolerance is acquired upon treatment with non-specific immunosuppressive drugs. This indiscriminate immunosuppression of the patient often causes serious side-effects, such as opportunistic infectious diseases. Therefore, the need for antigen-specific modulation of pathogenic immune responses is of crucial importance in the treatment of inflammatory diseases. In this perspective, dendritic cells (DCs) can have an important immune-regulatory function, besides their notorious antigen-presenting capacity. DCs appear to be essential for both central and peripheral tolerance. In the thymus, DCs are involved in clonal deletion of autoreactive immature T cells by presenting self-antigens. Additionally, tolerance is achieved by their interactions with T cells in the periphery and subsequent induction of T cell anergy, T cell deletion, and induction of regulatory T cells (Treg). Various studies have described, modulation of DC characteristics with the purpose to induce antigen-specific tolerance in autoimmune diseases, graft-versus-host-disease (GVHD), and transplantations. Promising results in animal models have prompted researchers to initiate first-in-men clinical trials. The purpose of current review is to provide an overview of the role of DCs in the immunopathogenesis of autoimmunity, as well as recent concepts of dendritic cell-based therapeutic opportunities in autoimmune diseases.



















 





Saturday, September 14, 2013

0 Regulatory T cells and regulation of allergic airway disease


Logo of ajcei









Am J Clin Exp Immunol. 2012; 1(2): 166–178.

Published online 2012 November 15.




PMCID: PMC3714190





Regulatory T cells and regulation of allergic airway disease








Abstract



Diseases like asthma have dramatically increased in the last decades. The reasons for the rising prevalence are still controversially discussed. Besides the genetic predisposition a number of different causes are thought to affect the increase of allergies. These include the hygiene hypothesis as well as changes in intestinal microbiota. Allergic airway inflammation is driven by T cells but it has become clear that tolerance and also suppression of allergic inflammation are mediated by so called regulatory T cells (Tregs). Indeed, naturally occurring Treg as well as induced Tregs have been shown to suppress allergic airway disease. In addition, the effectiveness of different therapeutic strategies (e.g. allergen immunotherapy) are mediated via Tregs. In addition, several Treg based approaches have been shown to effectively suppress allergic airway disease in different models. However, more research is needed to explore these potentially interesting approaches for the treatment of human disease.


Keywords: Allergy, asthma, inflammation, regulatory T cell, suppression








Formats:










Friday, September 13, 2013

0 IL-17A and Th17 Cells in Lung Inflammation: An Update on the Role of Th17 Cell Differentiation and IL-17R Signaling in Host Defense against Infection




Clinical and Developmental Immunology Volume 2013 (2013), Article ID 267971, 12 pages http://dx.doi.org/10.1155/2013/267971

Review Article

IL-17A and Th17 Cells in Lung Inflammation: An Update on the Role of Th17 Cell Differentiation and IL-17R Signaling in Host Defense against Infection



Center for Comparative Respiratory Biology and Medicine, University of California, Davis, CA 95616, USA

Received 16 March 2013; Accepted 27 June 2013

Academic Editor: Samuel Huber


Copyright © 2013 Hsing-Chuan Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.



Abstract


The significance of Th17 cells and interleukin- (IL-)17A signaling in host defense and disease development has been demonstrated in various infection and autoimmune models. Numerous studies have indicated that Th17 cells and its signature cytokine IL-17A are critical to the airway’s immune response against various bacteria and fungal infection. Cytokines such as IL-23, which are involved in Th17 differentiation, play a critical role in controlling Klebsiella pneumonia (K. pneumonia) infection. IL-17A acts on nonimmune cells in infected tissues to strengthen innate immunity by inducing the expression of antimicrobial proteins, cytokines, and chemokines. Mice deficient in IL-17 receptor (IL-17R) expression are susceptible to infection by various pathogens. In this review, we summarize the recent advances in unraveling the mechanism behind Th17 cell differentiation, IL-17A/IL-17R signaling, and also the importance of IL-17A in pulmonary infection.



0 DNA Methylation Profiles of Airway Epithelial Cells and PBMCs from Healthy, Atopic and Asthmatic Children


Open Access

RESEARCH ARTICLE


DNA Methylation Profiles of Airway Epithelial Cells and PBMCs from Healthy, Atopic and Asthmatic Children







Dorota Stefanowicz1, Tillie-Louise Hackett1,2, Farshid S. Garmaroudi1, Oliver P. Günther3, Sarah Neumann4, Erika N. Sutanto5,7, Kak-Ming Ling7, Michael S. Kobor4, Anthony Kicic5,6,7, Stephen M. Stick5,6,7, Peter D. Paré1,8, Darryl A. Knight1,2*

1 James Hogg Research Centre at the Heart and Lung Institute, Department of Medicine, University of British Columbia and St. Paul’s Hospital, Vancouver, British Columbia, Canada, 2 Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada,3 Prevention of Organ Failure Centre of Excellence, Vancouver, British Columbia, Canada, 4 Department of Medical Genetics Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada, 5 Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, Western Australia, Australia, 6 School of Paediatrics and Child Health, University of Western Australia, Nedlands, Western Australia, Australia, 7 Telethon Institute for Child Health Research and Centre for Child Health Research, University of Western Australia, Nedlands, Western Australia, Australia, 8 Respiratory Division, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada


Abstract Top


Background


Allergic inflammation is commonly observed in a number of conditions that are associated with atopy including asthma, eczema and rhinitis. However, the genetic, environmental or epigenetic factors involved in these conditions are likely to be different. Epigenetic modifications, such as DNA methylation, can be influenced by the environment and result in changes to gene expression.

Objectives


To characterize the DNA methylation pattern of airway epithelial cells (AECs) compared to peripheral blood mononuclear cells (PBMCs) and to discern differences in methylation within each cell type amongst healthy, atopic and asthmatic subjects.

Methods


PBMCs and AECs from bronchial brushings were obtained from children undergoing elective surgery for non-respiratory conditions. The children were categorized as atopic, atopic asthmatic, non-atopic asthmatic or healthy controls. Extracted DNA was bisulfite treated and 1505 CpG loci across 807 genes were analyzed using the Illumina GoldenGate Methylation Cancer Panel I. Gene expression for a subset of genes was performed using RT-PCR.

Results


We demonstrate a signature set of CpG sites that are differentially methylated in AECs as compared to PBMCs regardless of disease phenotype. Of these, 13 CpG sites were specific to healthy controls, 8 sites were only found in atopics, and 6 CpGs were unique to asthmatics. We found no differences in the methylation status of PBMCs between disease phenotypes. In AECs derived from asthmatics compared to atopics, 8 differentially methylated sites were identified including CpGs in STAT5A and CRIP1. We demonstrate STAT5A gene expression is decreased whereas CRIP1 gene expression is elevated in the AECs from asthmatic compared to both healthy and atopic subjects.

Discussion


We characterized a cell specific DNA methylation signature for AECs compared to PBMCs regardless of asthmatic or atopic status. Our data highlight the importance of understanding DNA methylation in the epithelium when studying the epithelial contribution to asthma.



0 Dr. Christina Ciaccio reviews the cells and tissues of the immune system.



Dr. Christina Ciaccio reviews the cells and tissues of the immune system.  Held on Oct 22, 2012.


Conferences On-Line Allergy





Tuesday, September 10, 2013

0 Expression of IL-7 receptor in human peripheral regulatory T cells


Logo of ams









Arch Med Sci. 2013 June 20; 9(3): 555–560.

Published online 2012 October 30. doi:  10.5114/aoms.2012.31387




PMCID: PMC3701966





Expression of IL-7 receptor in human peripheral regulatory T cells








Abstract




Introduction


Regulatory T cells (Tregs, CD4 + CD25high Foxp3+) play a crucial role in allergy and other inflammatory diseases. However, the isolation of viable Tregs on the basis of intracellular expression of specific Forkhead Box Protein P3 (Foxp3) is difficult. In this study we checked if the expression of IL-7 receptor (CD127) on the Tregs could be a useful marker for isolation of viable Treg Foxp3+ cells.



Material and methods


Twenty-five patients sensitized to grass pollen with allergic rhinitis (AR) and ten healthy subjects were included. We compared Foxp3 expression in different CD4+ T cell subsets by flow cytometry and we assessed the relationship between the expression of Foxp3 and CD127 within regulatory T cells.



Results


Within the CD4+ lymphocytes 3.68 ±2.0% showed expression of Foxp3, 51.82 ±8.03% of CD4+CD25highwere Foxp3 positive (Foxp3+), whereas 82.12 ±5.4% of CD4+CD25highCD127low were Foxp3+. High intracellular expression of Foxp3 correlated with low superficial CD127 expression (r = 0.42, p = 0.017). There were no significant differences regarding the analysed markers between AR patients and healthy controls.



Conclusions


Regulatory T cells may be purified from the fresh peripheral blood as viable regulatory Foxp3 bright cells using CD4, high expression of CD25 and low expression of CD127 antigen.



Keywords: allergy, cytokines, inflammation, rhinitis, regulatory lymphocytes








Formats: